Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a

Neuropediatrics

Volumn 37, Issue 4, 2006, Pages 257-260

  Pakdaman, H ^a   Fallah, A ^a   Sahraian, Mohammad Ali ^b,c   Pakdaman, R ^b   Meysamie, A ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Beta interferon; Early onset multiple sclerosis; MS treatment

Indexed keywords

BETA1A INTERFERON;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GROUPS BY AGE; HUMAN; INJECTION SITE REACTION; MALE; MULTIPLE SCLEROSIS; MYALGIA; PRIORITY JOURNAL; RELAPSE;

ADOLESCENT; BIOLOGICAL RESPONSE MODIFIERS; CHILD; DISABILITY EVALUATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; INTERFERON-BETA; MULTIPLE SCLEROSIS;

EID: 33846195114     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924723     Document Type: Article

References (11)

1. Adams AB, Tyor WR, Holden KR. Interferon beta-1b and childhood multiple sclerosis. Pediatr Neurol 1999; 2: 481-483
2. Ghezzi A. Clinical characteristics of multiple sclerosis with early onset. Neurol Sci 2004; 24: S336-339
3. Ghezzi A, on behalf of the Immunomodulatory Treatment of Early onset MS (ITEMS) Group. Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study. Neurol Sci 2005; 26: S183-186
4. Koch-Henriksen N, Sorensen PS, Christensen T, Frederiksen J, Ravnborg M, Jensen K et al. A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis. Neurology 2006; 66: 1056-1060
5. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452
6. Mikaeloff Y, Moreau T, Debouverie M, Pelletier J, Lebrun C, Gout O et al. Interferon-beta treatment in patients with childhood-onset multiple sclerosis. J Pediatr 2001; 139: 443-446
7. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnosis criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231
8. Ozakbas S, Idiman E, Baklan B, Yulug B. Childhood and juvenile onset multiple sclerosis: Clinical and paraclinical features. Brain & Development 2003; 25: 233-236
9. Simone IL, Carrara D, Tortorella C, Liguori M, Lepore V, Pellegrini F et al. Course and prognosis in early-onset MS. Comparison with adult-onset forms. Neurology 2002; 59: 1922-1928
10. Ruggieri M, Iannetti P, Polizzi A, Pavone L, Grimaldi LME. Multiple sclerosis in children under 10 years of age. Neurol Sci 2004; 25: S326-335
11. Waubant E, Hietpas J, Stewart T, Dyme Z, Herbert J, Lacy J et al. Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics 2001; 32: 211-213